Physician profile
Afton Smith
NPI 1548505704
$2,978.29
in general payments reported to CMS, 2019-2025
9 companies · $522 in 2025
The $522 reported for 2025 was more than what 77% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $529 · 2023: $387 · 2024: $1,539 · 2025: $522.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,632 · Travel and Lodging: $803 · Education: $13.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,631.95 |
| Travel and Lodging | $803.38 |
| Education | $13.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,669.11 | 2021-2024 | Linq II |
| Boston Scientific Corporation | $542.37 | 2021-2025 | Watchman Flx, Accolade Sr, Bodyguardian |
| Abbott Laboratories | $464.04 | 2023-2024 | Aveir, Jot Dx, Amplatzer Amulet |
| Philips North America LLC | $115.66 | 2023 | |
| Janssen Pharmaceuticals, INC | $88.46 | 2021-2024 | Xarelto |
| Abiomed | $41.13 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.26 | 2023 | Lifevest |
| Pfizer INC. | $19.91 | 2023 | |
| Biosense Webster, INC. | $16.35 | 2024 | Carto 3 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Afton Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.